The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from Moderna.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
